Finance

Lists
WOCKPHARMA:NSE
Wockhardt Ltd
₹1,844.00
-0.31%
(-5.70) 1D
Jul 24, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for WOCKPHARMA...
Open
₹1,835.10
High
₹1,859.00
Low
₹1,825.70
Mkt. cap
299.64B
Avg. vol.
892.14K
Volume
330.10K
P/E ratio
140.81
52-wk high
₹2,422.30
52-wk low
₹1,086.70
EPS
₹13.10
Shares outstanding
110.69M
No. of employees
3K
Open
₹1,835.10
High
₹1,859.00
Low
₹1,825.70
Mkt. cap
299.64B
Avg. vol.
892.14K
Volume
330.10K
P/E ratio
140.81
52-wk high
₹2,422.30
52-wk low
₹1,086.70
EPS
₹13.10
Shares outstanding
110.69M
No. of employees
3K
News stories
From sources across the web
Profile
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia
About Wockhardt Ltd
CEOMurtaza Khorakiwala
Employees2.56K
Founded1967
Headquarters-
SectorPharmaceutical industry
Websitewockhardt.com
Last report
May 4, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
10.54B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
7.38B
7.82B
8.88B
10.54B
Cost of goods sold
2.64B
2.33B
3.17B
4.03B
Cost of revenue
2.64B
2.33B
3.17B
4.03B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.71B
1.86B
1.81B
1.90B
Operating expense
4.29B
4.42B
4.63B
4.19B
Total operating expenses
6.93B
6.75B
7.80B
8.22B
Operating income
450.00M
1.07B
1.08B
2.32B
Other non operating income
200.00M
210.00M
250.00M
-710.00M
EBT including unusual items
-1.09B
910.00M
670.00M
1.89B
EBT excluding unusual items
-120.00M
910.00M
770.00M
1.52B
Income tax expense
-10.00M
90.00M
60.00M
250.00M
Effective tax rate
0.92%
9.89%
8.96%
13.23%
Other operating expenses
2.02B
2.03B
2.17B
1.76B
Net income
-900.00M
780.00M
590.00M
1.66B
Net profit margin
-12.20%
9.97%
6.64%
15.75%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
70.00M
Interest expense
-480.00M
-550.00M
-600.00M
-450.00M
Net interest expenses
-480.00M
-550.00M
-600.00M
-380.00M
Depreciation and amortization charges
560.00M
530.00M
650.00M
530.00M
EBITDA
842.50M
1.62B
1.47B
2.74B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer